Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

ImmunityBio, Inc. IBRX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.50
+73.5%

Il y a eu 50 transactions d'initiés récentes enregistrées pour ImmunityBio, Inc. (IBRX), dont 21 achats et 28 ventes. Le total des achats d'initiés s'élève à $5.43M et le total des ventes d'initiés à $5.15M.

Les initiés notables ayant une activité récente comprennent Soon-shiong Patrick, Simon Barry J., Selecky Christobel. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — IBRX

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-03-31 Soon-shiong Patrick 10 Percent Owner, Officer: See Remarks Conversion (Vente) - $5.43 - -
2026-02-24 Simon Barry J. Director Vente Informative 75,000 $12.01 $900.79K 2,850,821
2026-02-23 Simon Barry J. Director Vente Informative 165,000 $10.25 $1.69M 2,925,821
2026-02-23 Selecky Christobel Director Vente Informative 25,000 $10.00 $250K -
2026-02-22 Soon-shiong Patrick 10 Percent Owner, Officer: See Remarks Exercice d'Options (Vente) 114,329 - - 114,329
2026-02-22 Lauer Regan J Chief Accounting Officer Exercice d'Options (Vente) 4,065 - - 4,065
2026-02-22 Simon Barry J. Director Exercice d'Options (Vente) 15,243 - - 15,245
2026-02-22 Adcock Richard CEO & President Exercice d'Options (Vente) 152,439 - - 152,439
2026-02-22 Sachs David C. Chief Financial Officer Exercice d'Options (Vente) 40,650 - - 40,651
2026-02-20 Simon Barry J. Director Vente Informative 10,000 $9.25 $92.5K 3,081,604
2026-02-10 Soon-shiong Patrick 10 Percent Owner, Officer: See Remarks Exercice d'Options (Vente) 274,122 - - 548,246
2026-02-10 Lauer Regan J Chief Accounting Officer Exercice d'Options (Vente) 5,482 - - 10,965
2026-02-10 Adcock Richard CEO & President Retenue Fiscale RSU 140,048 $6.93 $970.53K 485,465
2026-02-10 Sachs David C. Chief Financial Officer Exercice d'Options (Vente) 82,236 - - 164,474
2026-01-20 Simon Barry J. Director Vente Informative 75,000 $7.88 $590.93K 3,091,604
2026-01-20 Selecky Christobel Director Vente Informative 25,000 $7.51 $187.65K -
2026-01-16 Selecky Christobel Director Vente Informative 50,000 $5.00 $250K -
2025-12-31 Adcock Richard CEO & President Exercice d'Options (Vente) 34,483 - - 51,731
2025-12-31 Sachs David C. Chief Financial Officer Exercice d'Options (Vente) 30,397 - - 45,602
2025-12-12 Wendel Bruce Director Inconnu - - - -
2025-12-12 Wendel Bruce Director Attribution de RSU 146,020 $2.36 $344.61K 146,020
2025-06-18 Clark Wesley Director Attribution de RSU 162,786 $2.84 $462.31K 162,786
2025-06-18 Blaszyk Michael D Director Attribution de RSU 162,786 $2.84 $462.31K 162,786
2025-06-18 Cohen Cheryl Director Attribution de RSU 162,786 $2.84 $462.31K 162,786
2025-06-18 Maxwell Linda Director Attribution de RSU 162,786 $2.84 $462.31K 162,786
2025-06-18 Selecky Christobel Director Attribution de RSU 162,786 $2.84 $462.31K 162,786
2025-02-22 Soon-shiong Patrick 10 Percent Owner, Officer: See Remarks Exercice d'Options (Vente) 114,329 - - 228,658
2025-02-22 Lauer Regan J Chief Accounting Officer Exercice d'Options (Vente) 4,065 - - 8,130
2025-02-22 Simon Barry J. Director Exercice d'Options (Vente) 15,243 - - 30,488
2025-02-22 Adcock Richard CEO & President Exercice d'Options (Vente) 152,439 - - 304,878
2025-02-22 Sachs David C. Chief Financial Officer Exercice d'Options (Vente) 40,650 - - 81,301
2025-02-10 Soon-shiong Patrick 10 Percent Owner, Officer: See Remarks Attribution de RSU 822,368 - - 822,368
2025-02-10 Lauer Regan J Chief Accounting Officer Attribution de RSU 16,447 - - 16,447
2025-02-10 Adcock Richard CEO & President Attribution de RSU 822,368 - - 822,368
2025-02-10 Sachs David C. Chief Financial Officer Attribution de RSU 246,710 - - 246,710
2025-01-22 Simon Barry J. Director Exercice d'Options (Vente) 110,020 $2.00 $219.86K -
2024-12-31 Adcock Richard CEO & President Exercice d'Options (Vente) 34,483 - - 86,214
2024-12-31 Sachs David C. Chief Financial Officer Exercice d'Options (Vente) 30,397 - - 75,999
2024-12-15 Lauer Regan J Chief Accounting Officer Exercice d'Options (Vente) 21,031 - - -
2024-12-10 Soon-shiong Patrick 10 Percent Owner, Officer: See Remarks Autre (Achat) - $5.43 - -
2024-06-11 Clark Wesley Director Attribution de RSU 77,633 $5.96 $462.69K 77,633
2024-06-11 Blaszyk Michael D Director Attribution de RSU 77,633 $5.96 $462.69K 77,633
2024-06-11 Cohen Cheryl Director Attribution de RSU 77,633 $5.96 $462.69K 77,633
2024-06-11 Maxwell Linda Director Attribution de RSU 77,633 $5.96 $462.69K 77,633
2024-06-11 Brennan John Owen Director Attribution de RSU 77,633 $5.96 $462.69K 77,633
2024-06-11 Selecky Christobel Director Attribution de RSU 77,633 $5.96 $462.69K 77,633
2024-02-22 Soon-shiong Patrick 10 Percent Owner, Officer: See Remarks Attribution de RSU 342,987 - - 342,987
2024-02-22 Lauer Regan J Chief Accounting Officer Attribution de RSU 12,195 - - 12,195
2024-02-22 Simon Barry J. Director Attribution de RSU 45,731 - - 45,731
2024-02-22 Adcock Richard CEO & President Attribution de RSU 457,317 - - 457,317
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message